Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 2, 2022
has subject area
- 11 Medical and Health Sciences (FoR)
- Diabetes Mellitus, Type 2 (MeSH)
- Endocrinology & Metabolism (Science Metrix)
- Glycation End Products, Advanced (MeSH)
- Humans (MeSH)
- Kidney (MeSH)
- Renal Insufficiency, Chronic (MeSH)
published in
- Diabetes Care Journal